Clin2
NCT07118930Possibly a fitRecruiting

Testing sivelestat sodium for heart bypass patients

Coronary Heart DiseaseCoronary Artery DiseaseCoronary Arterial Disease (CAD)

Part of Heart & circulation clinical trials.

This trial tests if an anti-inflammatory drug called sivelestat sodium can help people recover after heart bypass surgery. It is for patients having planned bypass surgery on at least two heart arteries.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
62 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are having planned heart bypass surgery (off-pump) on at least two blood vessels.
  • Your heart pumps at least 35% of blood out each beat (LVEF 35% or higher).
  • Your liver and kidneys are working well enough (certain lab tests are within limits).
  • You have not taken strong anti-inflammatory drugs or immune-suppressing medicines in the last 30 days.
  • You do not have an active infection, an autoimmune disease, or a history of allergies to the study drug.
  • You are not having an emergency surgery or a procedure that also fixes a heart valve or the main artery from the heart.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06730802Not yet recruiting
Cholesterol drug to reduce inflammation after heart bypass surgery

This trial tests whether a medicine that lowers cholesterol can also reduce inflammation and protect organs during and after heart bypass surgery. If you are having bypass surgery soon, this study may help improve your recovery.

Beijing, Beijing Municipality
NCT07078370Enrolling by invitation
Testing a lab-made blood vessel for heart bypass surgery

This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.

Poznan
NCT06434935Enrolling by invitation· Early Phase 1
Trial of a new bypass graft for heart surgery

This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.

Asunción
NCT05635227Recruiting
Medications during heart surgery to help control breathing and circulation

This study looks at whether giving dexamethasone and olanzapine during certain heart surgeries can improve how blood flow and ventilation (breathing support) are managed. It’s meant to see if these medicines help the body handle heart-lung bypass more safely.

Copenhagen
NCT07594509Not yet recruiting
Vericiguat before and after heart surgery

This trial tests whether the drug vericiguat, taken before and after heart surgery, can help protect the heart and reduce the risk of heart failure. It may help people who have heart problems going into surgery.

Nanjing, Jiangsu
NCT06195267Recruiting
Sivelestat for lung protection during emergency aortic surgery

This study tests whether a drug called sivelestat can protect your lungs and other organs during emergency surgery for a very serious aortic tear. If you qualify, you would receive the drug or a placebo right before and after surgery.

Beijing

Hear when a new Coronary Heart Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.